ICON plc
(NASDAQ : ICLR)

( )
ICLR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. -0.11%17.936.5%$167.21m
HZNPHorizon Therapeutics Plc -3.04%48.826.5%$144.10m
CTLTCatalent, Inc. 1.35%79.062.3%$137.76m
MYOKMyoKardia, Inc. -0.69%103.261.8%$131.39m
BHCBausch Health Cos., Inc. 1.06%19.130.0%$126.12m
VRXValeant Pharmaceuticals International, Inc. 1.06%19.1314.1%$112.56m
UTHRUnited Therapeutics Corp. 2.15%125.7014.3%$76.32m
ICPTIntercept Pharmaceuticals, Inc. 1.71%76.6716.8%$63.16m
ARGXargenx SE -1.02%230.340.0%$59.52m
JAZZJazz Pharmaceuticals Plc 0.74%118.742.4%$57.11m
GWPHGW Pharmaceuticals Plc 1.02%128.576.2%$54.50m
AMRNAmarin Corp. Plc -2.78%6.641.6%$51.62m
AXSMAxsome Therapeutics, Inc. -2.05%74.251.9%$46.44m
PRGOPerrigo Co. Plc -1.49%55.546.8%$42.66m
ICLRICON plc -0.85%169.484.3%$40.99m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.